D. Y. Acik Et Al. , "Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?," BMC CANCER , vol.19, no.1, 2019
Acik, D. Y. Et Al. 2019. Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?. BMC CANCER , vol.19, no.1 .
Acik, D. Y., Bankir, M., Baylan, F. A., & Aygun, B., (2019). Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?. BMC CANCER , vol.19, no.1.
Acik, Didar Et Al. "Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?," BMC CANCER , vol.19, no.1, 2019
Acik, Didar Y. Et Al. "Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?." BMC CANCER , vol.19, no.1, 2019
Acik, D. Y. Et Al. (2019) . "Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?." BMC CANCER , vol.19, no.1.
@article{article, author={Didar Yanardag Acik Et Al. }, title={Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?}, journal={BMC CANCER}, year=2019}